ArticleNature medicine2021

Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial.

Thomas Powles et al.PubMed ↗Publisher ↗

No numbers read from the abstract.